Business Description
Biotest AG
NAICS : 325412
ISIN : DE0005227201
Share Class Description:
HAM:BIO: Ordinary SharesCompare
Compare
Traded in other countries / regions
BIO.Germany IPO Date
1999-01-04Description
Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The company covers preclinical and clinical development of the preparations, plasma collection, production, as well as marketing and sales.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 46.31 | |||||
9-Day RSI | 46.17 | |||||
14-Day RSI | 47.58 | |||||
3-1 Month Momentum % | 12.5 | |||||
6-1 Month Momentum % | 0.49 | |||||
12-1 Month Momentum % | -1.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | 2.27 | |||||
OCF Margin % | 2.27 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 27.47 | |||||
EV-to-Forward-EBIT | -67.92 | |||||
EV-to-Forward-EBITDA | 211.32 | |||||
EV-to-Forward-Revenue | 3.35 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biotest AG Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 635.2 | ||
| EPS (TTM) (€) | -0.65 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.44 | ||
| 3-Year Sortino Ratio | -0.64 | ||
| Volatility % | 14.67 | ||
| 14-Day RSI | 47.58 | ||
| 14-Day ATR (€) | 1.25536 | ||
| 20-Day SMA (€) | 40.92 | ||
| 12-1 Month Momentum % | -1.9 | ||
| 52-Week Range (€) | 33 - 42.8 | ||
| Shares Outstanding (Mil) | 39.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biotest AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biotest AG Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| 3:1 Stock Split | 2015-07-15 | 25.02 (+0.00%) |
Show
Entries
Biotest AG Frequently Asked Questions
What is Biotest AG(HAM:BIO)'s stock price today?
The current price of HAM:BIO is €40.00. The 52 week high of HAM:BIO is €42.80 and 52 week low is €33.00.
When is next earnings date of Biotest AG(HAM:BIO)?
The next earnings date of Biotest AG(HAM:BIO) is .
Does Biotest AG(HAM:BIO) pay dividends? If so, how much?
Biotest AG(HAM:BIO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Biotest AG
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers